Inicio › Cáncer de vejiga › Texas › Dallas
Ensayos clínicos de Cáncer de vejiga en Dallas, TX
27 estudios para Cáncer de vejiga buscan participantes en centros de Dallas y alrededores (a unos 30 millas). Abra un estudio para ver quién puede participar y cómo contactar con el equipo.
Texto oficial del estudio (inglés)
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
ReclutandoFase 2
- UT Southwestern Simmons Cancer Center - RedBird, Dallas
- UT Southwestern/Simmons Cancer Center-Dallas, Dallas
A Study to Learn About the Study Medicine PF-08052667 in People With Bladder Cancer
ReclutandoFase 1
- Cancer Center Outpatient Building, Dallas
- The University of Texas Southwestern Medical Center, Dallas
- UT Southwestern Medical Center - West Campus Building, Dallas
- y 2 más
FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3
ReclutandoFase 1
- University of Texas Southwestern, Dallas
- Texas Oncology, P.A, Dallas
Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Removal After Treatment Shrinks Muscle Invasive Bladder Cancer, BRIGHT Trial
ReclutandoFase 2
- Parkland Memorial Hospital, Dallas
- UT Southwestern Simmons Cancer Center - RedBird, Dallas
- UT Southwestern/Simmons Cancer Center-Dallas, Dallas
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemotherapy Treatment for Bladder Cancer, ARCHER Study
ReclutandoFase 3
- Parkland Memorial Hospital, Dallas
- UT Southwestern/Simmons Cancer Center-Dallas, Dallas
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
ReclutandoFase 3
- Parkland Health and Hospital System, Dallas
- UT Southwestern Medical Center, Dallas
Measuring Surgical Recovery After Radical Cystectomy
ReclutandoEstudio observacional
- University of Texas - Southwestern, Dallas
Enfortumab Vedotin and Stereotactic Radiation for Localized Bladder Cancer
ReclutandoFase 1/2
- UT Southwestern Medical Center, Dallas
DESTINY-PANTUMOUR04
ReclutandoEstudio observacional
- Research Site, Dallas
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
ReclutandoEstudio observacional
- UT Southwestern Medical Center, Dallas
Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC
ReclutandoFase 2
- Urology Clinics of North Texas, PLLC, Dallas
- UT Southwestern Medical Center, Dallas
Artificial Intelligence Prediction Tool in Non-muscle Invasive Bladder Cancer (NMIBC)
ReclutandoEstudio observacional
- University of Texas Southwestern Medical Center, Dallas
Study of Datopotamab Deruxtecan Plus Carboplatin or Cisplatin Versus Gemcitabine Plus Carboplatin or Cisplatin in Participants With Locally Advanced or Metastatic Urothelial Carcinoma
ReclutandoFase 2/3
- Research Site, Dallas
LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve
ReclutandoFase 1/2
- UT Southwestern Medical Center, Dallas
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
ReclutandoFase 2
- Baylor Scott & White Research Institute, Dallas
A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2
ReclutandoFase 2
- Baylor Scott and White Research Institute, Dallas
An Open-label Study to Investigate the Efficacy and Safety of Dato-DXd + Rilvegostomig vs SoC in Adult Participants With High-risk MIUC
ReclutandoFase 3
- Research Site, Dallas
A First in Human Study of PLT012 in Participants With Solid Tumor Cancers
ReclutandoFase 1
- NEXT Dallas, Dallas
Predicting BCG Response
ReclutandoEstudio observacional
- University of Texas Southwestern, Dallas
Study to Assess the Impact of the Urine Test Cxbladder Triage Plus on the Number of Cystoscopies Performed on Patients With Invisible Blood in Their Urine.
Reclutando
- UT Southwestern Medical Center, Dallas
Specimen Collection for Validation of UroAmp: A Next Generation Sequencing Platform for Detection and Surveillance of Bladder Cancer
ReclutandoEstudio observacional
- UT Southwestern Medical Center, Dallas
Bladder Cancer Screening Trial
Reclutando
- University of Texas Southwestern Medical Center, Dallas
Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors
ReclutandoFase 1/2
- NEXT Oncology - Dallas, Dallas
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
ReclutandoFase 1
- Mary Crowley Cancer Research, Dallas
- Baylor University Medical Center, Dallas
A Novel Multiplex ELISA Assay for Evaluating Patients With Microscopic Hematuria for Bladder Cancer
ReclutandoEstudio observacional
- UT Southwestern Medical Center at Dallas, Dallas
Blue Light Cystoscopy With Cysview® Registry
ReclutandoEstudio observacional
- UT Southwestern, Dallas
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
ReclutandoEstudio observacional
- Massive Bio SYNERGY-AI site, Dallas
Más información sobre Cáncer de vejiga en MedlinePlus
Ensayos de Cáncer de vejiga en otras ciudades
- New York City, NY36 estudios
- Nashville, TN31 estudios
- Houston, TX31 estudios
- Boston, MA26 estudios
- Washington, DC26 estudios
- Los Angeles, CA25 estudios
- Baltimore, MD24 estudios
- Philadelphia, PA23 estudios
- Edison, NJ23 estudios
- St. Louis, MO22 estudios
- Chicago, IL21 estudios
- Seattle, WA21 estudios
Otros estudios en Dallas
- Cáncer de seno54 estudios
- Cáncer de pulmón de células no pequeñas53 estudios
- Cáncer metastásico44 estudios
- Fallo cardíaco42 estudios
- Cáncer (todos los tipos)40 estudios
- Cáncer de próstata39 estudios
- Cáncer del colon y del recto34 estudios
- Obesidad33 estudios
- Cáncer de ovario31 estudios
- Cáncer de pulmón26 estudios
- Cáncer de endometrio25 estudios
- Cáncer de riñón (carcinoma de células renales)24 estudios
De ClinicalTrials.gov, datos obtenidos el 15 nov 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.